What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Vikran Engineering (NSE: VIKRAN) Q3 FY26 results show solar-led order book surge as margins reset during execution ramp-up
Ducon Infratechnologies (NSE: DUCON) Q3 FY26 results signal margin pressure even as carbon capture and AI bets move closer to execution
Read More 5 minute read Pharma Industry News Plus Therapeutics wins major reimbursement milestone as Humana approves CNSide cerebrospinal fluid assay Find out how Plus Therapeutics secured Humana’s national coverage for the CNSide assay and what it means for metastatic CNS cancer care today. bySoujanya RaviNovember 20, 2025